The Latest Breaking News from Alzheimer Disease

Researchers say the test could help ‘predict onset of disease early in a non-invasive fashion’

Research supports idea that components in human blood can influence formation of new brain cells

Research supports idea that components in human blood can influence formation of new brain cells

Researchers establish a blood-based test that could predict risk of the condition at an earlier stage

The research supports the idea that components in human blood can influence the formation of new brain cells.

Researchers may have found an unlikely contributor to the development of Alzheimer’s disease: the bacteria in your gut. Their study, published in the journal Science, suggested that certain gut bacteria increase the brain damage seen in mice with an Alzheimer’s-like disease.

Though Alzheimer’s disease affects more than 55 million people worldwide, there’s still no cure for the condition – and treatment options are limited.

One in nine Americans ages 65 and over had Alzheimer’s disease in 2022, and countless others were indirectly affected as caregivers, health care providers and taxpayers. There is currently no cure – available treatments primarily focus on prevention by encouraging protective factors, such as exercise and healthy diet, and reducing…

Research suggests hormone replacement therapy may reduce risk of Alzheimer’s in some women

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.

The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.